Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.200
-0.050 (-2.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Century Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-9.58-126.57-136.67-130.93-95.82
Upgrade
Depreciation & Amortization
13.113.313.048.443.75
Upgrade
Other Amortization
--0.090.30.31
Upgrade
Asset Writedown & Restructuring Costs
6.764.3316.37--
Upgrade
Loss (Gain) From Sale of Investments
-2.36-4.81-3.98--
Upgrade
Stock-Based Compensation
6.8412.6914.6210.674.73
Upgrade
Other Operating Activities
-4.090.2-1.21.630.83
Upgrade
Change in Accounts Payable
1.56-1.47-2.36-4.79-1.85
Upgrade
Change in Unearned Revenue
-109.16-6.59-2.24117.99-
Upgrade
Change in Other Net Operating Assets
-6.95-1.2213.9810.75-0.95
Upgrade
Operating Cash Flow
-103.88-110.14-88.3514.05-89
Upgrade
Capital Expenditures
-0.85-0.15-13.74-30.6-44.97
Upgrade
Cash Acquisitions
--9.61---
Upgrade
Investment in Securities
108.3557.2474.8717.48-253.37
Upgrade
Investing Cash Flow
107.547.4861.13-13.13-298.34
Upgrade
Long-Term Debt Repaid
---10.24--
Upgrade
Net Debt Issued (Repaid)
---10.24--
Upgrade
Issuance of Common Stock
0.1774.560.5227.16277.07
Upgrade
Other Financing Activities
-----18.92
Upgrade
Financing Cash Flow
0.1774.56-9.7327.16417.77
Upgrade
Net Cash Flow
3.811.91-36.9428.0830.43
Upgrade
Free Cash Flow
-104.72-110.29-102.08-16.55-133.97
Upgrade
Free Cash Flow Margin
-95.93%-1673.84%-4567.52%-318.37%-
Upgrade
Free Cash Flow Per Share
-1.21-1.40-1.72-0.29-4.14
Upgrade
Cash Interest Paid
--0.591.10.97
Upgrade
Cash Income Tax Paid
-0.52.52-0.01
Upgrade
Levered Free Cash Flow
-97.2149.44-71.09-79.59-96.45
Upgrade
Unlevered Free Cash Flow
-97.2149.44-70.85-79-95.96
Upgrade
Change in Working Capital
-114.55-9.289.38123.95-2.8
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.